Welcome Back
Join CoinTime
Sign in with email
Sign up with email
Check your inbox
Dexcom
About
Dexcom develops, manufactures, and distributes continuous glucose monitoring systems for diabetes management.
- San Diego,California,United States
- 5001 - 10000
- http://www.dexcom.com
Details
- Last Funding Type
- Post-IPO Equity
- Last Funding Money Raised
- $7.22M
- Industries
- Biotechnology,Health Care,Manufacturing,Medical Device
- Founded date
- Jan 1, 1999
- Number Of Employee
- 5001 - 10000
- Operating Status
- Active
- Stock Symbol
- nasdaq:DXCM
- Legal Name
- DexCom, Inc.
DexCom, Inc. is a leader in continuous glucose sensing technologies, and focuses 100% on these technologies. Founded in 1999, DexCom’s roots stem from the pioneering 1967 research on implanted glucose sensors at the University of Wisconsin. DexCom started with a focus on creating an implantable Sensor that the body would not reject and that would perform for a long period of time.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 9, 2017 | Post-IPO Debt | $350M | — | — | — | Detail |
| May 2, 2016 | Post-IPO Equity | $7.22M | — | — | — | Detail |
| Apr 12, 2012 | Post-IPO Equity | $3.96M | — | — | — | Detail |
| Apr 14, 2005 | IPO | $56.40M | — | — | — | Detail |
| Jan 6, 2005 | Series D | $22.50M | 4 | — | — | Detail |
Investments
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Jun 17, 2020
Current Health
|
Series A | £3.32M | Health Care | Yes |
|
Jan 8, 2019
Beta Bionics
|
Series B | $63M | Biotechnology | — |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Canaan Partners
|
— | Series D |
RWI Group
|
— | Series D |
St. Paul Venture Capital
|
— | Series D |
Warburg Pincus
|
— | Series D |
Federated Kaufmann Fund
|
— | Series C |
Fog City Capital
|
— | Series C |
Windamere Venture Partners
|
— | Series C |
Employee Profiles
Exits
Dexcom has had 1 exits. Dexcom most notable exits include Current Health
| Date | Company Name | Exit Type | Industry | |
|---|---|---|---|---|
| Oct 12, 2021 | Current Health | M&A | Health Care | Detail |
Acquisition
Dexcom has acquired 3 organizations. Their most recent acquisition was SweetSpot Diabetes Care on Feb 29, 2012. They acquired SweetSpot Diabetes Care for $8.50M.
|
Date
Company Name
|
Industry | Acquisition Type | Price | |
|---|---|---|---|---|
|
Feb 29, 2012
SweetSpot Diabetes Care
|
Analytics | — | $ 8.50M | Detail |
|
May 2, 2016
Nintamed
|
Information Technology | acquisition | — | Detail |
|
Aug 22, 2018
TypeZero Technologies
|
Cloud Computing | acquisition | — | Detail |
